Jarrod Longcor
Chief Operating OfficerMr. Jarrod Longcor served as Chief Business Officer of Cellectar Biosciences, Inc., since September 18, 2017 until February 2022 and serves as its Chief Operating Officer since February 22, 2022. He served as Senior Vice President of Corporate Development and Operations at Cellectar Biosciences, Inc. since July 15, 2016 until September 18, 2017. He has pharmaceutical and biotech experience and during that time was either responsible for or participated in more than 40 collaborations. He served as the Chief Business Officer of Avillion LLP since September 2014. He served as Vice President of Corporate Development at Melinta Therapeutics, Inc. (formerly, Rib-X Pharmaceuticals, Inc.) since July 2011. In this role, he was responsible for identifying and concluding several critical collaborations for the company, including a major discovery collaboration with Sanofi Aventis. From July 2009 to June 2011, he served as Senior Director of Business Development at Melinta Therapeutics, Inc. and served as its Director of Business Development from October 2007 to July 2009. He joined Melinta Therapeutics, Inc. in 2007. His experience includes served as a Senior Director of Business Development at MaxCyte, Inc., where he was responsible for developing regional partnerships and Senior Director of Business Development of Advancis Pharmaceutical Corporation, where he was responsible primarily for the establishment and management of multiple partnerships. He holds a B.S. from Dickinson College, a M.S. from Boston University School of Medicine and an MBA from Saint Joseph's University's Haub School of Business.
公司职务
- 公司名称Cellectar Biosciences, Inc.股票代码CLRB职务Chief Operating Officer
